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ABSTRACT Antagonism of glutamate-receptor responses activated by N-methyl-D-aspartic acid (NMDA) was studied using whole
cell voltage clamp recording from mouse dissociated hippocampal neurons cultured for 10-15 d. The kinetics of onset of and
recovery from NMDA receptor block during continuous application of NMDA together with either glycine, or L-alanine, were
recorded in response to concentration jump application of NMDA- and glycine-binding site directed competitive antagonists,
applied with a multibarrel flow pipe under conditions which allowed rapid solution changes around the cell < 10 ms. Mathematical
solutions for both one- and two-equivalent site models for competitive antagonism were determined according to the differential
equations outlined by Colquhoun and Hawkes (1977. Proc. R. Soc. Lond. B. 199:231-262). The kinetics of action of D-CPP and
D-AP5, NMDA binding site antagonists, and 7CI-kynurenic acid, a glycine binding site antagonist, were examined for each model.
For all these antagonists, the kinetics for the onset of and recovery from antagonism were better fit by the two-equivalent site
model, which yielded antagonist microscopic kBff/kBO, values which closely approximated K, values determined from analysis of
equilibrium dose response curves. These results suggest that two molecules of NMDA and two molecules of glycine must bind to
the NMDA receptor for activation of ion channel gating.
INTRODUCTION
Excitatory amino acid receptors in the mammalian
central nervous system have been broadly divided into
two major subtypes: N-methyl-D-aspartate (NMDA)
and DL-a-amino-3-hydroxy-5-methyl-4-isoxazolepropri-
onic acid (AMPA)/kainate preferring receptors. Both
subtypes can be activated by L-glutamate, and at many
central synapses both NMDA and AMPA/kainate recep-
tors contribute to the excitatory synaptic potential (Dale
and Roberts, 1985; Huettner and Baughman, 1988;
Forsythe and Westbrook, 1988). Characterizing the
kinetics of ligand binding to these subtypes of the
glutamate receptor family would enhance our under-
standing of the contribution each makes to synaptic
mechanisms in vivo (e.g., Lester et al., 1990). In this
paper, we analyze the kinetics of action of NMDA
receptor antagonists using concentration jump tech-
niques.
In equilibrium studies, with 3 ,uM glycine present
continuously, excitatory amino acid potency for NMDA
receptor activation varies over a 1,000-fold range, from
an EC50 = 2.3 p,M for L-glutamate to an EC50 = 2.3 mM
for quinolinate (Verdoorn et al., 1989; Patneau and
Mayer, 1990). For all agonists the Hill Coefficient,
determined from a fit of the logistic equation to agonist
activated currents, was > 1, indicating that more than
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one NMDA agonist binding site on the receptor needs
to be occupied for activation of ion channel gating; at
low concentrations of NMDA the limiting slope of a
double log plot of the dose response curve has a value
near two (Patneau and Mayer, 1990).
At the molecular level, the activation of NMDA
receptors is complicated by the fact that glycine appears
to act as a co-agonist which is absolutely required for
activation of ion channel gating (Johnson and Ascher,
1987; Kleckner and Dingledine, 1988; Vyklicky, et al.,
1990), suggesting that both glutamate and glycine must
occupy independent ligand binding sites before transi-
tions to the open state can occur. Also, NMDA activated
currents undergo desensitization, a component of which
is sensitive to glycine concentration (Mayer et al., 1989;
Lerma et al., 1990; Vyklicky et al., 1990). Recently, we
have suggested that this glycine-sensitive desensitization
results from the NMDA receptor existing in two states
with different affinities for glycine (Benveniste et al.,
1990a).
The analysis of dose response curves for the action of
agonists does not always distinguish clearly between
models with one, or more than one molecule of agonist
required for activation of ion channel gating (e.g., Bean,
1990). One- and two-site models for receptor activation
can be better distinguished by analysis of the kinetics of
the response to concentration jump application of ago-
nist, since a one-site model predicts an exponential
activation time course, while two-site models predict
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sigmoidal kinetics. However, with whole cell recording,
high concentrations of agonist are required to yield large
responses with a sufficient signal-to-noise ratio for
kinetic analysis; with these conditions the rate of solu-
tion exchange and not the kinetics of agonist binding can
become the limiting factor which determines the time
course of receptor activation, unless, e.g., very rapid
solution changes are achieved (Lester et al., 1990). This
makes distinction between one- and two-site models
difficult. Also, for both models, deactivation kinetics
following removal of agonist are described by single
exponential functions. In contrast to the rapid kinetics of
action of agonists, the kinetics of onset of and recovery
from block by the NMDA receptor competitive antago-
nists, i.e. 3-([+]-2-carboxypiperazin-4-yl)-propyl-1-phos-
phonic acid (D,L-CPP) and D-2-amino-5-phosphonopen-
tanoic acid (D-AP5) (Olverman and Watkins, 1989) are
relatively slow and less likely to be influenced by the rate
of solution exchange (Benveniste et al., 1990b). Further-
more, the kinetics of both onset of and recovery from
competitive antagonist block of agonist-activated re-
sponses are distinct for one and two binding site models.
This is useful because analysis of the kinetics of agonist-
activated responses during the rapid application of
competitive antagonists can thus provide insight as to the
number of agonist occupied sites required for activation
of ion channel gating, in addition to providing useful
information on antagonist binding kinetics.
In our previous experiments, antagonist association-
and dissociation-rate constants (k,on and k,,.., respec-
tively) were determined by single exponential analysis of
the response to concentration jump application of D-AP5
and D,L-CPP in the presence of 100 ,uM NMDA and 3
p,M glycine (see Benveniste et al., 1990b), with a
correction for receptor occupancy by agonist applied
during analysis of the rate of onset of antagonist action
(1/T0.) according to the equation:
(Ks) because the ratio kB&ff/kB,n was only 1.5-fold different
from the value determined from analysis of antagonist
equilibrium dose-response curves fit with a single bind-
ing site isotherm. However, for D-AP5 and the glycine
site directed NMDA receptor antagonist, 7CI-kynurenic
acid (Kemp et al., 1988), the ratio kB,ff/kB.. differed
10.6-fold and 10.8-fold, respectively, from Ki values
determined from equilibrium dose-response analysis
(Benveniste et al., 1990b). The approximation of Eq. 1 is
true only for conditions in which the kinetics of agonist
binding and ion channel gating are much faster than
those for the kinetics of antagonist binding, such that
agonist and antagonist binding are always in equilibrium
with the receptor during changes in the concentration of
antagonist (Krouse et al., 1985). In the presence of 100
,uM NMDA, the time constant for onset of block by 30
P,M D-AP5 determined by single exponential analysis
(31.1 8.3 ms), was comparable to the time constant of
decline in response to NMDA after rapid removal of
agonist (27.2 + 4.2 ms), indicating that the rates of
channel closure and dissociation of agonist were likely to
influence the rate of association of D-AP5 (Benveniste et
al., 1990b), and thus invalidate the conditions required
in Eq. 1.
In an attempt to obtain better correspondence be-
tween kinetic and equilibrium measurements for D-AP5
and 7CI-kynurenic acid, we determined rate constants
for antagonist binding from fits of analytically solved
equations predicting receptor occupancy, and used one-
and two-site models for analysis of antagonist equilib-
rium dose response curves as appropriate. We show here
that the kinetics of antagonism for both the NMDA
binding site antagonists D-CPP and D-AP5, as well as the
glycine binding site antagonist 7CI-kynurenic acid, are
well fit by a model based on the assumption that the
NMDA receptor has two binding sites each for gluta-
mate and glycine.
1
=fkB3on[B]I + kBof' (1)
where
J- [A]'
1+ EC50
A and B represent agonist and antagonist, respectively,
and EC,, is the dose of agonist which produces a half
maximal response (Krouse et al., 1985). With this
analysis, the estimates obtained for association and
dissociation rate constants for D,L-CPP were good predic-
tors of the antagonist equilibrium dissociation constant
MATERIALS AND METHODS
Culture conditions and
electrophysiology
Neurons were cultured from a dissection of E16-E18 C57BV/6 mouse
hippocampi as previously described (Mayer et al., 1989), and plated on
a glial feeder layer which has been cultured for 2-3 wk before the
neuronal dissection. To create the feeder layer, P1 mouse hippocampi
were dissected and plated at 125,000 cells per ml and grown in Eagles
minimum essential medium (MEM) + 10% fetal calf serum. When the
cell layer was confluent, the cultures were treated with fluoro-
deoxyuridine (55 ,uM, final concentration) to arrest cell division.
Neurons were plated at 25-50,000 cells per ml and were maintained in
MEM + 5% horse serum + an insulin-transferrin nutrient supplement
(Guthrie et al., 1987). Experiments were generally performed 10-14 d
after the neuronal plating.
Neurons were voltage clamped at -60 mV with an Axoclamp 2
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amplifier (Axon Instruments) operating in the discontinuous mode at
a switching frequency of - 10 kHz, Experiments were performed at
room temperature (24-270C). Extracellular solution consisted of (in
millimolar): NaCl, 160; KCl, 2.5; CaCl2, 2; MgCl2, 1; glucose, 10;
Hepes, 10; 10 Lg/ml phenol red; and was titrated to pH 7.3 with NaOH
and adjusted to 325 mOsm. 400 nM tetrodotoxin and 5 FM bicuculline
methochloride were added to block action potential discharge and
spontaneous inhibitory synaptic currents, respectively. The intracellu-
lar solution consisted of (in millimolar): CsMeSO3, 125; CsCl, 15;
CaCl2, 0.5; MgCl2, 3; CsBAPTA, 5; and MgATP, 2. The solution was
titrated to pH 7.2 with CsOH and adjusted to 305 mOsm. Agonist and
antagonist solutions were similar to control extracellular solution but
contained only 0.2mM Ca (to reduce desensitization) and were devoid
of Mg (to prevent ion channel block). Intracellular calcium was
strongly buffered with 5 mM BAPTA, to minimize activation of
Ca-dependent ionic currents secondary to calcium influx through
NMDA receptor channels. To further minimize the effects of desensi-
tization, NMDA was applied at 10 ,uM, and glycine was present at 3
,uM (Benveniste et al., 1990a; Vyklicky et al., 1990).
Rapid solution changes were made as previously detailed (Vyklicky
et al., 1990). Briefly, a nine barrel flowpipe array (internal diam 356
pm per barrel) was positioned -100 p,m from the cell soma. A
solution containing both agonist and antagonist was applied to the cell
soma and surrounding dendrites. After the response to this solution
reached equilibrium, a stepper motor moved the flowpipe array so that
the adjacent barrel containing only agonist was positioned in front of
the cell soma. A valve controller then simultaneously stopped the flow
of the first solution and initiated the flow of the antagonist-free
solution causing the cell to respond with an increase in inward current.
After the new equilibrium response was reached, the stepper motor
returned the flowpipe array to its original position. When this was
achieved, application of the solution containing both agonist and
antagonist commenced again; this resulted in a decrease in inward
current, as antagonist block developed. Previously, we have shown that
the time constant for solution exchange around the cell was - 10 ms or
less (Vyklicky et al., 1990).
D-CPP was a gift of J. C. Watkins, University of Bristol, UK. D-AP5
and 7CI-kynurenic acid were purchased from Tocris Neuramin (Buck-
hurst Hill, Essex, UK) and all other chemicals were from Sigma
Chemical Co. (St. Louis, MO) or Fluka (Buchs, Switzerland).
Theory and analysis
The theory for the kinetics of receptor activation in response to agonist
binding has already been described by Colquhoun and Hawkes (1977).
The same theory can be applied to describe the kinetics of binding of a
competitive antagonist in the presence of agonist. In deriving the
equations for the action of agonists and antagonists, we have assumed
that a receptor occupied by agonist is in rapid equilibrium with the
open state of the channel, and we have not modeled the opening and
closing transitions explicitly. A result of this simplification is that rate
constants derived for binding and dissociation of agonist are apparent
values, which reflect both agonist binding and ion channel gating
kinetics. As presented in the Discussion, we believe that this simplifica-
tion does not affect the accuracy of our analysis of experimental results
with antagonists, and the values we present for antagonist association-
and dissociation-rate constants should be close to their true values.
From Colquhoun and Hawkes (1977) we know that the differential
equation:
dP(t)
dIt = P(t)Q (2)
has the following solution which is a sum of exponential functions:
k
P(t) = P(0) , Ae-it,
ia-
(3)
where P(t) is a vector composed of probabilities of the receptor
occupying each of k states at time t, and Q is the matrix of transitions
between the states described below. X, are the eigenvalues of Q. Ai =
mini, where ni denotes the ith row vector of matrix N and mi denotes
the ith column vector of matrix M. N equals M-' andM is composed of
k column eigenvectors of Q. Because mi are eigenvectors of Q, matrix
A, has special properties (Eq. 16 and 17 in Colquhoun and Hawkes,
1977) which allow the solution of P(t) to be written in the form of Eq.
3. P(O) represents a vector of initial probability of receptor state
occupancies before the addition or removal of antagonists. In our
experiments, we can only measure current flowing through open
channels, which is correlated to the probability of the occupancy of the
third receptor state, P3(t), as defined in all of the following schemes.
The fitting procedure can be streamlined by fitting only P3(t) instead of
the entire P(t) vector, using the solution:
k
P3(t) = P(O) I Aij3exi%
i-I
(4)
where Ai3 symbolizes the third column of matrixAi.
One binding site model
For a one-site model of competitive antagonism we can summarize
agonist and antagonist binding reactions as:
[1] k [3]
A + B + R AR
kson qIkw°
BR
[2]
where [1], [2], and [3] represent the receptor, R, in the unbound,
antagonist bound and agonist bound states, respectively, and A
represents the agonist and B the competitive antagonist. The ion
channel is assumed to be closed in states [1] and [2] and open in state
[3]. The macroscopic transition matrix Q is composed of elements, qij,
where the ith row represents the initial receptor state before the
transition, and thejth column represents the final receptor state after
the transition. The transition element, qij, for ligand association
reactions is represented by the association-rate constant (kAon for
agonist and kEon for antagonist) multiplied by ligand concentration, and
for dissociation reactions qij is the concentration independent dissocia-
tion-rate constant (kAf, for agonist and kE,5ff for antagonist). For the
one-site model depicted above, the transition matrix is:
-(kAon[AI + kBn[B]) kBon[B] kAonl[AI'
Q - k Boff -kBoff 0
kAoff 0 -kAoff .
The probability of occupancy of the receptor by agonist can be
determined explicitly after diagonalizing Q, by creating the A, matrices
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and solving Eq. 4. Then, the onset of current block after a rapid
concentration jump application of antagonist is proportional to:
P3(t) =q13q21
otI3
q3q21 - t(q13P1(O) + P3(0)(ql3 + q12 + q21)) + P3(0)a e2|~~~~~~~LO - D a
-q3q21 (q13P1(O) + P3(0)(ql3 + q12 + q21)) + P3(0)
-t
13~~~~~~~~(13-a ) e> ,
(5)
where
a, =
- (q31 + q12 + q13 + q21)
2
± V(q31- q2- q13 + q21)2 + 4ql2ql3
2
After setting kB,,[B] = 0 in matrix Q, recovery from antagonist block
recorded after a concentration jump to antagonist-free solution, is
proportional to:
P(t q= 3 P2(O)q13 eq22t
q13-q33 q22 + q13-q33
(P3[o0 4 433 e (6)
Eqs. 5 and 6 are the sum of 3 exponentials as predicted by Eq. 4, where
the constant term e't, when = 0, represents the time-independent
steady-state level of occupancy for the activated state of the receptor.
Analysis of the response to antagonist utilizing these equations was
performed using fixed values for kAOfn and kA,f, the apparent rate
constants for agonist association and dissociation according to a single
binding site model. A single exponential was fit to the rise in current in
response to agonist applied alone and k, determined from a plot of
l/TO vs. agonist concentration (Benveniste et al., 1990b). The exponen-
tial time constant, Trff, was measured from the decline in the current
trace in response to removal of agonist, and the agonist apparent
microscopic dissociation-rate constant (kAm,ff) was determined as l/Tff.
The response to a concentration jump application of antagonist
recorded with agonist present continuously contained two relaxations
in our experimental protocol: the response to removal of antagonist,
followed by the response to reapplication of antagonist; for all models
these responses were analyzed together in pairs. First, the antagonist
dissociation-rate constant, kBff, was determined iteratively, by fitting
the time course of the increase in NMDA receptor current following
step removal of antagonist to Eq. 6, and letting both the antagonist
association-rate and dissociation-rate constants vary. Fitting of all the
models was accomplished using a nonlinear Simplex fitting procedure
(Kowalik and Osborne, 1968) which minimized the sum of the squared
differences between the experimental data and the calculated current
transient deduced from the sum ofk exponentials according to Eq. 4. A
unique solution for kBff determined for the one-site model could not
be obtained without an additional constraint, thus the ratio of kBgff/kB,f
was constrained to within three-fold of the Ki value determined from
equilibrium dose response analysis. This constraint was not necessary
for any of the other fitting procedures described below. With kBoff
obtained from the previous fit now fixed, kBon for the one-site model
was redetermined iteratively, by fitting the decline ofNMDA receptor
current recorded following the reapplication of antagonists to Eq. 5.
A two binding site model
Values for kAOn and kAOff, the apparent microscopic rate constants for
agonist association and dissociation were re-evaluated for a two-
equivalent site model for agonist action by analysis of the response to
concentration jump application of agonist. In this case, Toff was
obtained as described above, and kAoff determined as 1/2'Tff. The
macroscopic transition matrix for the two equivalent site model for
agonist action according to the scheme:
Ill kmf [21 2kAf [31
A + R AR '- ARA
2kAn kAon
is given by:
-2kAoj[A] 2kAo4[A] 0
Q = kAff -(kAof[A] + kAOff) kAOf[A]
0 2kAoff -2kAoff,
The coefficient of 2 in the matrix of macroscopic transitions from states
[1] to [2] and from states [3] to [2] results from the summation of two
microscopic transitions into and out of these states, with identical
microscopic rate constants (Colquhoun and Ogden, 1988). After
diagonalization of the above macroscopic transition matrix, the eigen-
values and eigenvectors can be incorporated into Eq. 4 yielding the
explicit solution for the probability for occupancy of the activated
state, ARA, of:
PAO= (4 + ( q23 e-2(q2i+q23)t
21 + q23 21 + q23
- 2 q2 e-(q21+q23)t (7)
from which the agonist apparent microscopic association-rate constant
(k,ion) can be obtained iteratively.
The two-equivalent site model for competitive antagonism, in which
state [3] is the activated receptor channel complex [ARA], can then be
described as:
[1]
A + B + R
2kBon kBff
BR
[4]
kBo. 2kBoff
BRB
[6]
k,ff
2kA,on
[2]
AR
kB.n1 kB°ff
ARB
[5]
2kAoff
kA,,,
[3]
ARA
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where the transition matrix is:
r-2(kAOfl[A] + k..[B])
kAGff
0
kBoff
0
0
2 kAO[AI 0
- (kB.,[B] + kAoff + kAOf[AI) kAon[AI
2kAoff
0
kBoff
0
- 2 kAff
2 kB.[B]
0
0
0 - (kA0n[A] + kB,n[B] + koff)
0
0
kAOff
2kB,ff
0
0
kAo.[A]
- (kAoff + kBoff)
In contrast to the above cases, this two-site analysis for the onset of and
recovery from antagonist evoked block could not be solved explicitly in
terms of kBo, and kB,ff. This results from the fact that a model with six
receptor states has a 6 x 6 transition matrix Q which would yield a
sixth order polynomial that cannot be solved analytically to determine
the eigenvalues. Thus, the eigenvalues were determined by numerical
approximation using IMSL routines. In this analysis, values for kAof
and kAOff were previously determined for the two-site model for agonist
action as described above, and held constant during the determination
of the antagonist microscopic rate constants. In each iteration, kB and
kB,ff were modified and eigenvalues and eigenvectors of Q determined.
First, kB,ff was determined by fitting the kinetics of the response to
removal of the antagonist, where the antagonist association- and
dissociation-rate constants were the freely variable parameters in the
Simplex fit. Although k.,0[B] was set equal toO in the transition matrix
for the fit of recovery from antagonist block, its value had to be
determined for the estimation of the values in the P(O) vector. The
calculated current transient is proportional to the sum of six exponen-
tials according to Eq. 4. At this point, the ratio kBoff/kw. determined
solely from the fit of recovery from antagonist block was usually within
two- to threefold of the Ki determined from equilibrium dose response
analysis. After kBff was determined, its value was fixed and kB.. became
the only variable rate constant used in fitting the response to
reapplication of antagonist later in the same current trace. Because
each of the models detailed above describes receptor occupancy and
not membrane current, an additional variable proportional to the
number of receptors and the single channel current had to be included
to convert receptor occupancy into a whole cell current response.
In the figures, the solid lines represent either a one- or two-site
analysis fit as appropriate. The range over which the solid line is drawn
represents the range of points over which the data was fit. Simulated
current transients were constructed by a numerical methods approach
as detailed elsewhere (Benveniste et al., 1990a).
Selection of analysis procedure
Analysis using one- and two-equivalent site models for NMDA
receptor block by competitive antagonists yielded better fits when the
kinetics of the response to antagonist removal were analyzed first to
determine kBff, and then the kinetics of the response to reapplication
of antagonist were analyzed second to determine kBon, using a fixed
value for 4.ff in the transition matrix. Curves were less well fit when
kB,ff and kBn were determined simultaneously by analyzing the re-
sponses to antagonist removal and reapplication in one fit. By fitting
the onset of, and recovery from antagonism simultaneously, estimated
values for kBn and kBff would be weighted equally for both phases of
the concentration jump response, although the time course of the
response to removal of antagonist contains no information pertaining
to the antagonist association-rate constant except for the initial
amplitude (P(O)). Thus, by fitting the response to removal of and
reapplication of antagonist separately, the analysis is likely to weight
the data more appropriately than in the case of a simultaneous fit.
RESULTS
Kinetic analysis of agonist-induced
currents
The analysis ofNMDA receptor responses during onset
of and recovery from antagonism according to the
analytically determined equations for the models de-
scribed in Materials and Methods requires prior analysis
of the response to agonist applied alone, since the
apparent rate constants for binding and dissociation of
agonist are held as fixed parameters during analysis of
antagonist responses. Although previous work suggests
that a single-site model for activation of NMDA recep-
tors is unlikely to be valid (Patneau and Mayer, 1990;
Benveniste et al., 1990a), we determined kAO, and kAoff for
both one- and two-site models for agonist action to be
able to check the validity of one- and two-site models for
antagonist action. These experiments were performed in
the presence of 3 FLM glycine. Within the limited
temporal resolution of our concentration jump experi-
ments, responses to NMDA were reasonably well fit by
both one- and two-site models for agonist action. For the
two-site model for agonist action the apparent associa-
tion rate constant for NMDA (kAOn), 2.08 + 0.9 puM`s`
(7 cells, 66 observations), was calculated iteratively
utilizing Eq. 7; for the one-site model kAon was deter-
mined as 1.12 uM`'s' from the slope of the plot of '/on"
estimated by single exponential analysis of the response
to application ofNMDA (Benveniste et al., 1990b). The
apparent microscopic dissociation-rate constant for
NMDA (kAOff) for the two-site analysis was determined
from single exponential fits to the decrease in membrane
current after removal of agonist, and is half of the value
(i.e., 1/2T0ff) calculated for a single binding site model.
Values for kAOff were determined to be 45.72 + 7.37 s-5
and 22.86 + 3.69 s-1 for one- and two-site models,
respectively. The ratio kAOff/kAon for the two-site model,
11.0 p,M, is in reasonable agreement with the micro-
scopic Kd of 16.4 ,M determined from a two-equivalent
site analysis of the NMDA equilibrium dose response
curve (Patneau and Mayer, 1990). An example of a
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response to NMDA fit by two-site analysis is shown in
Fig. 1.
For the glycine site of the NMDA receptor, the
kinetics of the response to concentration jump applica-
tion of both the high affinity agonist glycine, and the
low-affinity agonist L-alanine, were also analyzed using
both one- and two-site models for agonist action. Gly-
cine concentration jumps were performed in the pres-
ence of 10 ,uM NMDA. Two-site analysis gave estimates
for kAOf and kAOff of 13.61 + 0.9 l±M-'s-1 and 1.00 + 0.13
s-1, respectively (6 cells, 50 observations). Single exponen-
tial analysis of the response to concentration jump
A
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FIGURE 1 Kinetic analysis of the action of NMDA and L-alanine
according to a two-equivalent binding site model; solid lines indicate
the fit of a two-site model for agonist action. A and B are portions of a
continuous record of membrane current recorded in the presence of 3
pLM glycine during a concentration jump of 30 p,M NMDA. Analysis of
trace B gave 'rff = 28.1 ms, corresponding to a kAf = 17.79 s-5. Eq. 7
was used for analysis of the trace shown in A, yielding a kAOn = 1.61
.M1s-'. C shows that for NMDA mean values for kAo, (2.1 .M-'s-')
and k,, (23 s-') vary slightly with agonist concentration. D and E are
portions of a continuous record of membrane current recorded in the
presence 100 pM NMDA during a concentration jump of 20 pM
L-alanine. Analysis of trace D gave 'rff = 24.08 ms, corresponding to a
kAff = 20.76 s-'. Eq. 7 was used for analysis of the trace shown in
E, yielding a kAOf = 1.55 pM-'s-'. F shows that for L-alanine kAOfn
(1.7 pM-'s-') and kAoff (19.9 s-') do not vary appreciably with
concentration. Solid lines in C andF represent fits to the data by linear
regression analysis.
application of glycine with a one binding site model
yielded average estimates for kAOf = 10.4 p.M`s` and
kAoff = 2.00 + 0.25 s-'. These values were similar to those
previously reported for glycine applications in the pres-
ence of 100 ,uM NMDA (Benveniste et al., 1990b).
For responses to L-alanine recorded in the presence
of 100 ,uM NMDAvalues for kAon and kAOff determined by
two-site analysis were 1.73 + 0.51 .M-'s-1 and 19.88
2.87 s-5, respectively (6 cells, 96 observations). The
average values for kAon and kAoff for the one-site model
were 0.89 .M-'s-1 and 39.76 + 5.74 s-'. An example of
two-site kinetic analysis of the response to a concentra-
tion jump application of 20 ,uM L-alanine is illustrated in
Figs. 1, D and E. The ratio kAOff/kAOn for the two-site
model has a value of 11.5 ,uM, similar to the microscopic
Kd of 15.3 p.M determined from analysis of the L-alanine
equilibrium dose response curve by a two-equivalent site
model (data not shown).
Kinetic analysis of inhibition of
NMDA induced currents by D-CPP
and D-AP5
Although both one- and two-site models for agonist
action gave reasonable fits to concentration jump re-
sponses evoked by NMDA, for the response to NMDA
receptor antagonists much better fits were obtained with
the two-site model. Fig. 2 shows examples of the change
in membrane current recorded from hippocampal neu-
rons exposed to 10 p,MNMDA and 3 AM glycine, during
application of and removal of D-CPP and D-AP5. Com-
pared with our previous work (Benveniste et al., 1990b),
the kinetics of onset of block by D-AP5 were slightly
faster in the present experiments, consistent with reduc-
tion of the concentration of NMDA from 100-10 ,uM,
and a competitive interaction between D-AP5 and
NMDA.
Two-site analysis of the response to 1.5 and 6 ,uM
D-CPP, which dissociates slowly in comparison toNMDA
(10 ,uM), yielded mean values for kBon and k1,,ff of 3.6 +
1.4 p.M`s` and 1.1 + 0.1 s-5 (5 cells, 45 observations),
respectively. These values were within 1.5-fold of the
values previously determined by single exponential anal-
ysis and the correction factor given by Eq. 1 (Benveniste
et al., 1990b). For one-site analysis we obtained mean
values of 3.9 + 1.4 pM-'s-1 for kB., and 0.5 + 0.1 s-5 for
kBoff, but as illustrated in Figs. 2, A and B, fits of the
one-site model were not good. Two-site analysis of the
response to 11 and 15 F.M D-AP5 in the presence of 10
,uM NMDA and 20 ,uM D-AP5 in the presence of 30 p,M
NMDA, yielded mean values for kBon and kB&ff of 22.23 +
6.5 tLM-'s-' and 19.45 + 4.1 s5' (7 cells, 48 observations),
respectively. D-AP5, which dissociates rapidly compared
with D-CPP, has mean value for kBon that is 14.8 times
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FIGURE 2 Kinetic analysis of the action of D-CPP and D-AP5 fit with
one- and two-equivalent site models for competitive antagonism. Each
antagonist was applied by concentration jump in the presence of 10
pIM NMDA and 3 p,M glycine, with the responses to removal of, and
reapplication of antagonist displayed separately. TracesA and C show
digitized records of membrane current recorded during the removal of
6 ,M D-CPP (A) or 15 ,JM D-AP5 (C). Traces B andD show the onset
of antagonism during the reapplication of 6 FM D-CPP (B) or 15 pLM
D-AP5 (D). Solid lines in the left column indicate nonlinear least
squares fits to a one binding site model for antagonist action used to
determine the antagonist dissociation-rate constant (A and C) from
Eq. 6, or the antagonist association-rate constant (B and D) from Eq.
5. Solid lines in the right column represent nonlinear least squares fits
to a two binding site model for antagonist action as detailed in
Materials and Methods. For the one binding site analysis (left column),
the apparent rate constants for agonist binding were: k, = 1.12
PM-'s-'; kAff = 45.71 s-'; for the two equivalent site analysis (right
column), apparent rate constants for agonist action were: kAm = 2.08
pM's-; kAff = 22.86 s-1.
greater than that determined by single exponential
analysis, while the mean kB,ff values are similar (Table 1
and Benveniste et al., 1990b). For one-site analysis we
obtained mean values of 48.8 + 22.5 ,uM`s` for kBon and
12.1 + 3.0 s-5 for kB,ff; as noted for D-CPP, fits of the
one-site model to responses evoked by D-AP5 were not
good.
The goodness of fit of the one-site model (determined
from the residual sum of squared errors after curve
fitting with the Simplex algorithm) was heavily depen-
dent on the starting point chosen for the analysis, and on
the concentration of antagonist used. The goodness of fit
of the two-equivalent site model was less sensitive to the
starting point chosen for the analysis. In some cases,
responses to removal of and reapplication of antagonists
were better fit by a one-site model for antagonist action
than the examples shown in Fig. 2, but kBoff/kIn ratios
calculated from these responses were several-fold dif-
ferent from Ki values estimated using a single binding
site model to analyze equilibrium dose response curves
for antagonist action, consistent with errors in the
estimation of either antagonist rate constants or the
equilibrium value for Ki with single site models.
Our kinetic analysis for D-CPP and D-AP5 gave clearly
distinguishable fits for one- and two-site models (Fig. 2).
The better fit of the two-site model is consistent with
both equilibrium analysis of dose response curves for
activation of NMDA receptors (Patneau and Mayer,
1990), and with analysis of the kinetics of desensitization
at NMDA receptors (Benveniste et al., 1990a) which
both suggest two binding sites for NMDA. The simu-
lated response of a two-site model for antagonist action,
when fit with the one-site model used for analysis of
responses to D-CPP and D-AP5, showed striking similar-
ities between the poor fit of the one-site model to
experimental data, and the poor fit of the one-site model
to data simulated by the two-site model (compare Figs. 2
and 3). To understand the significance of an inadequate
fit for our models of antagonist action, it is important to,
realize that the degree of block at equilibrium, and the
kinetics of onset of and recovery from block are not
independent variables which can be freely adjusted to
obtain the best fit. Instead, the kinetics of antagonist
action are determined by kBn and kBff, while the ratio of
these values determines antagonist potency (Ki = kB&ff/
kB.n). The one-site model underestimates the degree of
block at equilibrium both before removal of antagonist
(Fig. 3 A), and following reapplication of antagonist
(Fig. 3 B). The response to removal of antagonist pre-
dicted by the one-site model does not reach steady state
as fast as either the response simulated by the two-site
model (Fig. 3 A), or experimental data recorded with
D-CPP and D-AP5 (Fig. 2). In contrast, the onset of
antagonism predicted by the one-site model reaches
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FIGURE 3 Analysis of two-site simulated responses by a one-site
model. The response to a concentration jump application of antagonist
was simulated by a two-site model for antagonist action (small circles)
and analyzed using a one-site model for antagonist action (solid line).A
shows recovery from antagonism, B the onset of antagonism. Values
for agonist and antagonist binding kinetics were chosen such that they
approximated the experimental values obtained with NMDA and
D-AP5. Parameters for two-site model simulation were: kAOf = 2
,M-s-', kAff = 23 s-', kBo, = 16 FM`s-', kE,.ff = 20 sI', [A] = 10 FM
agonist, [B] = 10 ,uM antagonist. To determine kAOf and kA,ff for the
one-site model analysis, the response of the two-site model to agonist
concentration jumps was simulated (not shown), and the results fit
with single exponential functions. Agonist and antagonist association
and dissociation rate constants obtained by one-site analysis of these
simulated responses were: kAO, = 1.2 pLM`'s-, kAOff = 46 s', kBof = 20.5
FM's1, kBoff = 9.9 s-1
steady state faster than the response simulated by the
two-site model for antagonist action (Fig. 3 B); a similar
discrepancy occurs for experimentally recorded re-
sponses to D-CPP and D-AP5 (Fig. 2).
The simulations shown in Fig. 3 were generated by a
two binding site model for antagonist action with associ-
ation and dissociation rate constants similar to those
found experimentally for D-AP5 and NMDA, and illus-
trate the response to instantaneous step application of
and removal of antagonist. The sigmoidal kinetics of the
response to removal of D-AP5 and D-CPP (Fig. 2) is thus
revealed in Fig. 3A to be a consequence of agonist and
antagonist binding kinetics, and not the kinetics of
solution exchange. The results of this simulation give
added confidence to our suggestion that a one-site
model for antagonism cannot accurately fit the kinetics
of responses to concentration jump application of com-
petitive NMDA receptor antagonists, but do provide
support for the two-site model as a satisfactory alterna-
tive.
Comparison between equilibrium
and kinetic measurements for
competitive antagonists
Although the one-site model for competitive antagonism
poorly fit the time course of the response to concentra-
tion jump application of D-CPP and D-AP5, the corre-
spondence between K1 values for D-CPP and D-AP5
calculated from analysis of antagonist equilibrium dose-
response curves using a single binding site model, with Ki
values calculated from the ratio k&,fflk&,fl also derived
using a single binding site model, was much better than
when single exponential analysis was used to analyze the
kinetics of antagonist responses (cf. Benveniste et al.,
1990b). This is because the single binding site model for
antagonist action does not require the assumption of
rapid re-equilibration of agonist and antagonist binding
during a concentration jump application of antagonist to
receptors pre-equilibrated with agonist (see Eq. 1).
From single site analysis, the ratio kB,ffI/kB. determined
for D-CPP was 0.15 + 0.06 ,uM, which is 1.5-fold less
than the K1 value determined from analysis of the
equilibrium inhibition of NMDA activated currents by
D-CPP fit using a single binding site isotherm. However,
for the fast dissociating antagonist D-AP5 the ratio
kB.ffI/kB,f determined by the one-site model for antagonist
action, 0.29 + 0.12 ,uM, is still fourfold less than the Ki
value determined from analysis of antagonist dose re-
sponse curves using a single binding site isotherm. For
these experiments, equilibrium dose-response analysis
was performed for five concentrations of D-CPP or
D-AP5 in the presence of 10 AM NMDA and 3 ,uM
glycine (Fig. 4,A and B).
For two-site analysis of the response to D-CPP, the
ratio kB,ffIk,o0 yields a microscopic Ki of 0.37 + 0.16 p,M
which is in excellent agreement with the equilibrium
microscopic K; of 0.40 + 0.02 ,uM determined from
analysis of antagonist dose response curves according to
the equation for equilibrium block using a two-site
model:
100
% of Control =
where K. represents the concentration at which the
number of binding sites occupied by agonist is reduced
by 0.5 at any fixed value of agonist concentration [A]. An
example of the dose-response curve for D-CPP fit with
this model is shown in Fig. 4 C. The antagonist micro-
scopic equilibrium dissociation constant, K,, is then
determined from the Cheng-Prusoff equation (Cheng
and Prusoff, 1973):
K.
1i=A]1 + [Al
d
(9)
where Kd is the apparent microscopic equilibrium disso-
ciation constant for binding of agonist, determined using
a two binding site model. For this analysis the micro-
scopic Kd for NMDA, 11.0 p,M, was calculated from the
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FIGURE 4 Equilibrium dose-response data for competitive NMDA
receptor antagonists analyzed with a two binding site model. A shows
responses to concentration jump application of 10 ,uM NMDA,
applied together with the indicated concentrations of D-AP5; 3 ,uM
glycine was present continuously. The activation of NMDA receptors
by agonist and the onset of antagonism by D-AP5 reach equilibrium
with similar kinetics. B shows similar responses, in a different neuron,
for D-CPP. Initially, the response to NMDA overshoots its equilibrium
value, because the onset of antagonism by D-CPP is slow to reach
equilibrium. C shows the equilibrium dose response curve for block of
the response to NMDA by D-AP5 and D-CPP; data points are the
mean ± S.D. ofvalues recorded from four neurons per antagonist. The
solid line drawn through the data points was obtained by a least squares
fit of Eq. 8, the equilibrium equation for a two binding site model.
ratio kAOff/kAOf determined by two-site analysis as de-
scribed above. Simulations of antagonist responses were
used to confirm that the determination of Ki from Eqs. 8
and 9 is valid for a two binding site model. For D-AP5
the ratio kBffI/kB,f = 0.92 0.23 ,uM, also in good
agreement with the microscopic Ki for D-AP5 of 1.93 +
0.28 ,uM determined from equilibrium dose response
analysis with a two-equivalent binding site model.
Kinetic analysis of inhibition of
NMDA induced currents by
7CI-kynurenic acid
Dose response analysis of equilibrium responses to
glycine at a constant concentration of NMDA have
yielded Hill coefficients ranging from 0.77 to 1.44 (Kleck-
ner and Dingledine, 1988; Lerma et al., 1990; Vyklicky et
al., 1990). Thus there is some uncertainty as to the
number of glycine binding sites on the NMDA receptor
which need to be occupied for activation of ion channel
gating. By performing kinetic analysis for the response
to an NMDA receptor glycine site competitive antago-
nist, analogous to the analysis performed for NMDA
receptor glutamate site competitive antagonists and
described above, we hoped to determine the stoichiome-
try of glycine binding sites for activation of the NMDA
receptor channel complex.
The antagonist used, 7CI-kynurenic acid, is a high
affinity, competitive, glycine-site directed NMDA recep-
tor antagonist, with only low affinity for the NMDA
binding site (Kemp et al., 1988). In order for the
on-response to application of competitive antagonists to
be fit properly by either one- or two-site models, we have
observed empirically that the data from concentration
jump experiments must show a decrease in the time
constant for onset of antagonism with increasing concen-
tration of antagonist. Previously, we have shown by
single exponential analysis that such a relationship does
not exist for the block of NMDA receptor responses by
7CI-kynurenic acid in the presence of glycine (Ben-
veniste et al., 1990b, see also Henderson et al., 1990).
However, when L-alanine was substituted for glycine,
the time constant for onset of antagonism by 7Cl-
kynurenic acid did become faster as the concentration of
antagonist was increased. The apparent microscopic
dissociation-rate constant for L-alanine is 20 times faster
than that for glycine (see above). Thus, we concluded
that the kinetics of dissociation of glycine were rate
limiting when compared with the association rate for
binding of 7CI-kynurenic acid to the NMDA receptor,
causing concentration-independent kinetics for the an-
tagonist action of 7CI-kynurenic acid. Consistent with
this, an off response to removal of agonist, of similar
kinetics to, or faster than the response to onset of
antagonist action, also was the minimal requirement for
two-site analysis, otherwise a unique solution to the
fitting procedure was not attainable. When 100 ,uM
L-alanine was used instead of 3 p,M glycine to promote
activation ofNMDA receptors, our data for the antago-
nist action of 7CI-kynurenic acid could be fit by both
one- and two-site binding models, but as described
below, fits were better with the two-site model.
The upper traces of Figs. 5, A and B show typical
results for fits of the onset of and recovery from NMDA
receptor antagonism evoked by 10 p,M 7CI-kynurenic
acid in the presence of 100 p,M NMDA and 100 ,uM
L-alanine according to a one-site model for antagonism
(Eqs. 5 and 6). Note that the apparent association- and
dissociation-rate constants for the agonist (L-alanine)
were determined by prior single exponential analysis as
described earlier. Again, the poor fit obtained is qualita-
tively similar to those for the action of the competitive
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two-site model analysis of the dose response curve for
equilibrium block of responses to 100 ,uM NMDA and 3
,uM glycine by 7CI-kynurenic acid. For the latter analysis
K. = 5.7 ,uM, and the microscopic Kd used in Eq. 9 was
73 nM. This was determined from the ratio of kAOff/kAO,
from kinetic analysis utilizing a two site model of glycine
concentration jumps (see above). These K, values for
7CI-kynurenic acid are also good agreement with mea-
surements from binding experiments (Kemp et al.,
1988).
KBon 59.28 M-1s-1
7CI-Kyn off
O.I. <
C4M
400 ms
C
10 jM 7CI-Kyn on cM
300 ms
FIGURE 5 Kinetic analysis of the action of 7CI-kynurenic acid accord-
ing to one- and two-binding site models. Traces show digitized records
of membrane currents recorded in the presence of 100 IM NMDA
and 100 ,M L-alanine during the removal of 10 ,M 7CI-kynurenic acid
(A), or its reapplication (B). Upper traces indicate data fit to a one
binding site model from which the antagonist dissociation-rate con-
stant (A) or association-rate constant (B) was determined. Agonist
kinetics for the one binding site model were: k, = 0.89 pM-'s-',
kA.ff = 39.76 s-'. Lower traces indicate the same data fit to a two
binding site model from which the antagonist microscopic dissociation-
rate constant (A) or microscopic association-rate constant (B) were
determined. Agonist kinetics for the two binding site model were:
kAOm = 1.73 ILM's', kAOff = 19.88 s-'.
NMDA antagonists D-CPP and D-AP5 shown in Fig. 2
and for the simulated response of a two-site model for
competitive antagonism shown in Fig. 3. Analysis of
responses to the removal and reapplication of 10 and 30
p,M 7CI-kynurenic acid in the presence of 100 ,M
L-alanine, yielded a mean kB,ff value derived by analysis
using the one-site model of 6.2 + 0.3 s-' and a mean kB..
of 31.1 9.4 p,M-'s-. This yielded a k&,ff/k&,f ratio of
0.22 + 0.08 p,M which is similar to the previously
determined steady state Ki (Benveniste et al., 1990b;
Vyklicky et al., 1990); however, this value has little
meaning because the curves were not well fit (Fig. 5).
In the lower traces of Figs. 5,A and B, the kinetics of
action of 7CI-kynurenic acid were reanalyzed for the
same experimental traces, but using the two-site model.
The onset of and recovery from antagonism are now well
fit. The average k,on for 7CI-kynurenic acid was 40.77 +
14.8 ±M-'s-1 and the average kBff was 10.68 + 0.5 s-' (6
cells, 24 observations). The microscopic K1 determined
from the ratio kB&ff/kB,n for the action of 7CI-kynurenic
acid in the presence of L-alanine is 0.30 + 0.10 ,uM. This
value is in good agreement with the value of 0.14 ,uM,
obtained from an independent determination of K1 by a
DISCUSSION
We have demonstrated that kinetic analysis of concentra-
tion jump data recorded with NMDA receptor competi-
tive antagonists can be used to differentiate between one
and two site models for activation of ion channel gating
by the agonists NMDA and L-alanine. For each of the
three antagonists studied, comparison ofKi values deter-
mined from the ratio of kB,ff/kB,f with Ki values deter-
mined from analysis of equilibrium dose response curves,
indicates that kinetic analysis utilizing either one- or
two-site models yielded better estimates of rate con-
stants for antagonist binding than exponential analysis
(Table 1). However, the goodness of fit to the time
course of antagonist action was much better for the two
site model. It should be noted that the two-site model
used for antagonist action does not require binding of
two molecules of antagonist for block of ion channel
activity; rather, binding of a single molecule of antago-
nist to either of a pair of identical agonist recognition
sites is sufficient to block activation of the receptor.
Kinetic analysis of the action of D-AP5 and D-CPP
confirms results from equilibrium dose-response analy-
sis with low concentrations of NMDA which indicated
that two molecules of agonist must bind to the NMDA
receptor for activation of ion channel gating (Patneau
and Mayer, 1990). However, in previous experiments
using equilibrium measurements, the stoichiometry of
activation of the NMDA receptor by glycine could not
be accurately assessed because the contamination of
experimental solutions by nanomolar concentrations of
endogenous glycine made it impossible to determine the
limiting slope of the glycine log-log dose response curve.
The kinetic experiments with 7CI-kynurenic acid de-
scribed here overcame this difficulty because they were
performed with high doses of the glycine-like agonist,
L-alanine (100 p,M), and thus contamination by nanomo-
lar concentrations of endogenous glycine is insignificant.
Our results clearly indicate the existence of a stoichiom-
etry of two for binding of glycine to the NMDA receptor
on hippocampal neurons. This is consistent with recent
biochemical analyses (Thedinga et al., 1989; Yeh et al.,
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TABLE 1 Comparison of kinetic and equilibrium measurements for antagonist action at the glutamate and glycine binding sites on NMDA
receptors, estimated using one- or two-equivalent site or single exponential analysis
kB.. kBoff kBoff/kBon K
,AM-Is-' s-' pA-I
D-AP5
Exponential Analysis 1.5 19.6 13.3 1.23
One Site Analysis 48.8 ± 22.5 12.1 ± 3.0 0.29 ± 0.12 1.09
Two Site Analysis 22.2 ± 6.5 19.4 ± 4.1 0.92 ± 0.23 1.93
D-CPP
Exponential Analysis 1.9* 1.4 0.7 0.23*
One Site Analysis 3.9 ± 1.4 0.5 ± 0.1 0.15 + 0.06 0.22
Two Site Analysis 3.6 ± 1.4 1.1 ± 0.1 0.37 ± 0.16 0.40
7CI-Kynurenic Acid
Exponential Analysis 3.0 8.5 2.8 0.26
One Site Analysis 31.1 ± 9.4 6.2 ± 0.3 0.22 ± 0.08 0.14
Two Site Analysis 40.8 ± 14.8 10.7 ± 0.5 0.30 ± 0.10 0.14
Note the unusually slow binding kinetics for D-CPP. Kj values were determined from equilibrium dose response analysis using one or two binding
site isotherms. The ratio k,Off/kBon is in good agreement Kj values for one- and two-site analysis but not for exponential analysis. Errors are given as
standard deviations. For exponential analysis (data from Benveniste et al., 1990b) * indicates that a racemic mixture of CPP was used and that the
kB,o value was multiplied by two, and the Kj value divided by two because only one optical isomer of CPP is a potent NMDA receptor antagonist
(Aebischer et al., 1989).
1990) and the results of our analysis of the kinetics of
desensitization at NMDA receptors (Benveniste et al.,
1990a). In Table 1, the rate constants for D-AP5, D-CPP,
and 7C1-kynurenic acid obtained from one- and two-
equivalent binding site analysis are compared with those
previously determined by single exponential analysis
(Benveniste et al., 1990b).
The kinetic analysis of our data made several impor-
tant assumptions, concerning the influence of ion chan-
nel gating on the kinetics of action of antagonists, the
effects of noninstantaneous solution changes, and the
existence of agonist and antagonist binding sites of
equivalent affinity for two-site models. These points are
discussed below.
Influence of ion channel opening and
closing rate constants on antagonist
responses
The models described in Materials and Methods repre-
sent a simplified subset of one- and two-site models
because the additional steps of ion channel opening and
closing were omitted (e.g., Cachelin and Colquhoun,
1989). As a result, our values for agonist microscopic
association- and dissociation-rate constants will be in
error; however, as described below, the effect of this on
the calculation of microscopic association- and dissocia-
tion-rate constants for antagonists is surprisingly small.
Simulations were performed for concentration jump
application of antagonists in which the two-equivalent
site model used for analysis of our experimental data
was used to fit simulated data generated by a two-site
model containing an extra transition, between a closed
state with two molecules of agonist bound and the open
state, with a ratio of opening to closing rate constants of
13/a. To generate the simulated data sets a and were
varied while the agonist and antagonist association- and
dissociation-rate constants were kept constant. The
simulated responses were then analyzed using the two-
site kinetic analysis program, in which the opening and
closing transitions were neglected. The apparent associ-
ation- and dissociation-rate constants determined from
this analysis (in which opening and closing kinetics were
ignored) were then compared with the original simu-
lated values.
To simulate responses similar to those evoked by the
fast dissociating antagonist D-AP5, values for kBon and
kBNff were set at 16 jiM`s` and 20 s-1, while kAO, and kAOff
were simulated as 2 puM-'s-' and 23 s-5, respectively, to
give responses similar to those evoked by NMDA. When
a was simulated at a > 200 s-I with 2 0.1, fits of the
two-site model to antagonist concentration jump re-
sponses were good at all concentrations of agonist and
antagonist. With values of a < 30 s-5, k,on was variable
and changed with antagonist concentration. As a result,
our model implies that there will be many openings per
burst. Single channel measurements ofNMDA receptor
activity, with mean open times between 2.5 and 7 ms,
yield experimental values for a close to or greater than
the 200 s-5 required for accurate analysis of antagonist
kinetics (Nowak et al., 1984; Ascher et al., 1988; Jahr
and Stevens, 1987; Howe et al., 1988; Cull-Candy and
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Usowicz, 1989; Jahr and Stevens, 1990). The analysis of
single channel data is less informative concerning values
for 13 because closed time constants within bursts deter-
mined from multi-exponential fits ranged from 7 ,us to
250 ms (Howe et al., 1988; Cull-Candy and Usowicz,
1989). In our simulations, with values for a 2 200 s-5, a
100-fold variation in from 10 to 1,000 s-5 produced less
than twofold variation in k% and kBff estimated from our
2-site analysis program in which transitions to the open
state were not explicitly modeled.
Effects of noninstantaneous
concentration jumps on antagonist
responses
The models described in Materials and Methods also
assumed instantaneous applications of agonist and antag-
onist. Analysis of data with this assumption is capable of
producing valid results in the case of noninstantaneous
solution changes, if the time course for agonist and
antagonist action is slower than the time required for a
solution change in the vicinity of the cell. Previously, we
have estimated the solution exchange time constant by
bathing cells in 50 ,uM kainate with 5 mM external
sodium and measuring the time course of the rise in
current recorded on jumping into a solution containing
165 mM external sodium (Vyklicky et al., 1990). The
time constant of this process was < 10 ms. With subse-
quent improvements to our system, and by choosing
neurons without extended processes, we can routinely
measure kinetics with exponential time constants of 7
ms.
We have conducted simulations to test the effect of a
noninstantaneous solution exchange on our analysis of
association and dissociation rates for agonists and antag-
onists. The parameters for simulation of agonist and
antagonist kinetics were the same as described in the
previous section. With a solution exchange time con-
stant of 5 ms the average value for kAon determined by
kinetic analysis assuming a two-site model was 1.6
uM-'s-', 20% lower than the parameter used in the
simulation. The mean value determined for kAoff, 20.1 s-',
was 12.5% lower than the parameter used for simula-
tion. However, for analysis of simulated responses to
applications of antagonists, at concentrations similar to
those used in our experiments, the value estimated for
k&,ff did not vary significantly from the parameter used
for simulation, while kBon increased only 8%. Even with a
solution exchange time constant of 10 ms, kBoff still did
not vary significantly from the simulation parameter of
20 s' while kn increased < 27%. The fact that the ratio
of k%,ffI/k%n for each antagonist tested was similar to its
respective Ki determined from equilibrium dose re-
sponse analysis also indicates that the effect of noninstan-
taneous concentration changes is not a major concern
for the ligands examined in the present experiments. For
slowly dissociating antagonists, like D-CPP, the effects of
noninstantaneous solution changes are inconsequential.
A different problem arises when the rate of onset of
block by high concentrations of antagonist becomes
limited by the time course of agonist dissociation, even
though the antagonist is applied with a fast solution
change. Using the above values for kAon, kAOff, kB,, and
kB,ff, analysis of simulated responses to application of 30
p,M antagonist (which produced > 99% inhibition), did
not yield a unique solution for kB1n, even though accurate
fits were obtained at lower concentrations of antagonist.
To avoid this complication, it is important to obtain
estimates for the kinetics of antagonist action over a
range of antagonist concentrations.
Models with nonequivalent binding
sites
A two-site model for competitive antagonism contains
12 microscopic transitions. If all the transitions were not
equivalent, then 24 rate constants would need to be
determined; however, when the two-sites are of equiva-
lent affinity the number of rate constants is reduced to 4.
Although a two equivalent site model was used in the
present analysis, agonist-preferring and antagonist-
preferring states have been proposed on the basis of
autoradiographic studies (Monaghan et al., 1988). Also,
we have suggested that the NMDA receptor can exist in
states with high and low affinity for NMDA, and high
and low affinity for glycine (Benveniste et al., 1990a).
The change in affinity for NMDA does not appear to be
dependent on excitatory amino acid binding site occu-
pancy as in the cases of normal positive and negative
cooperativity, but depends on occupancy by glycine of its
binding sites. Similarly, this model proposes the analo-
gous situation for glycine binding, namely: glycine affin-
ities change with occupancy of the binding sites for
NMDA. A two-equivalent site model for the NMDA/
AP5-CPP binding site can be used as a reasonable
approximation, provided that the glycine concentration
is kept high enough so that binding sites for NMDA will
exist in only one of the different affinity states. The
concentrations used for our experiments, 3 p,M glycine
and 100 ,uM L-alanine, are near the top of their
dose-response curves. The same argument holds for
measuring kinetics at the glycine site: NMDA concentra-
tions should either be low or high to force the receptor
into a single state for binding glycine.
D-CPP yielded an average kBn of 2.4 puM`s`1 at 6 p,M
and 4.7 pM-'s-' at 1.5 ,uM. Although k3Off did not vary
significantly over the same range, the approximate
twofold change in k,on with a fourfold change in antago-
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nist concentration was characteristic of all the antago-
nists tested. The variability in k,on recorded in our
experiments could result from the oversimplification of
our model as a result of not including explicit channel
opening and closing transitions, as discussed above, or
by the NMDA receptor having two nonequivalent ago-
nist binding sites, with fits constrained to a two equiva-
lent site model during our analysis. These simplifications
may also explain the slight deviation of agonist apparent
association and dissociation rate constants with concen-
tration. Also, responses to low concentrations of agonist
or antagonist were less well fit, most likely because the
poor signal-to-noise ratio does not provide enough
information for accurate kinetic analysis.
Comparison of glutamate and glycine
binding sites
Conformationally restricted competitive antagonists de-
veloped from phosphonic amino acid derivatives appear
to have unusually slow binding kinetics at the excitatory
amino acid recognition site on the NMDA receptor
complex. When experiments are performed under iden-
tical conditions, the glutamate recognition site on the
NMDA receptor behaves quite differently with respect
to conformationally restricted antagonists for both the
glycine binding site on the NMDA receptor, and the
excitatory amino acid binding site on the AMPA/kainate
receptor. For NMDA receptors the association-rate
constant for 7C1-kynurenic acid, a conformationally
restricted glycine site antagonist, is 11 times faster than
that for the NMDA binding site antagonist D-CPP. The
antagonist action of quinoxaline 6-cyano-7-nitroquinox-
aline-2,3-dione (CNQX), which is a potent, selective
non-NMDA receptor antagonist (Honore et al., 1988)
with considerable conformational restriction, also has
faster kinetics of action than D-CPP. Recovery from
CNQX-evoked block of responses to kainic acid occurs
rapidly (for a two binding site analysis the dissociation-
rate constant for CNQX is = 23 s-, i.e., 21 times faster
than that for D-CPP; Benveniste and Mayer, unpub-
lished observations). Because the potency of antagonist
action of CNQX on AMPA/kainate receptors is similar
to that of D-CPP on NMDA receptors, this implies that
the association-rate constant for binding of CNQX to
AMPA/kainate receptors must also be much faster than
that for binding of D-CPP to NMDA receptors, despite
the fact that CNQX is a more constrained molecule than
D-CPP.
Based on a comparison between CPP, CNQX, and
7CI-kynurenic acid, the limited data available from our
experiments suggests that conformational restriction of
competitive antagonists for glutamate receptors does
not as a rule produce ligands with slow association
kinetics. It is plausible that the excitatory amino acid
antagonist binding site on NMDA receptors has molecu-
lar features, such as a pocket of restricted accessibility,
which reduces the probability that molecules of CPP
colliding with their binding site will be in the correct
orientation for a successful interaction with the recep-
tor. Another possibility is that phosphonate antagonists
have unusual chemical or kinetic properties. Currently,
we are using the techniques described here in conjunc-
tion with a large series of competitive antagonists to
examine structural features which are responsible for
determining antagonist binding kinetics at the NMDA
receptor.
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